Condition: Rheumatic Arthritis · Interstitial Lung Disease in Patients With Rheumatoid Arthritis · Sponsor: Medical University Innsbruck
The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess the risk of these manifestations, a comprehensive range of functional and clinical evaluations will be performed and correlated with structural lung assessments using computed tomography (CT).
This description comes directly from the study's public registry record.
Thomas Sonnweber, MD, PhD · +43(0)51250482586 · Thomas.Sonnweber@i-med.ac.at
David Haschka, MD, PhD · david.haschka@i-med.ac.at
Always discuss trial participation with your own doctor first.
| Medical University Innsbruck | Innsbruck, Austria, Austria | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06965322